Literature DB >> 12269549

The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A.

V Tugnoli1, R Marchese Ragona, R Eleopra, R Quatrale, J G Capone, A Pastore, C Montecucco, D De Grandis.   

Abstract

After parotid surgery, gustatory sweating and flushing occur more frequently, the former reportedly in 15-100% of cases, while no reliable data are available for the latter. Although botulinum toxin (BoNT) is effective in controlling sweating, little is known about its effect on flushing. In 17 patients suffering from Frey's syndrome after parotid surgery, we studied the gustatory flushing phenomenon as compared to gustatory sweating, analyzing their frequency, area, type of stimulus and response to BoNT administration. Cutaneous blood flow (CBF) was monitored by laser Doppler flowmetry (LDF) on affected and unaffected areas of the cheek in basal conditions and after meals, before and then 1 month after starting the BoNT injections. The Minor test was used to identify the sweating area. Flushing was observed in 7 of 17 patients after masticatory activity, spicy meals or citrus fruits. No clinical data correlated with any presence of flushing. Flushing regressed completely after BoNT administration and CBF reached similar values in the affected and unaffected sites. No adverse effects were observed. BoNT administration proved an effective and safe treatment for gustatory sweating and flushing in patients with Frey's syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12269549     DOI: 10.1007/s10286-002-0026-x

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  7 in total

Review 1.  Autonomic diseases: management.

Authors:  Christopher J Mathias
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 2.  Treatment of complications of parotid gland surgery.

Authors:  R Marchese-Ragona; C De Filippis; G Marioni; A Staffieri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

Review 3.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

Review 4.  Auriculotemporal Syndrome (Frey Syndrome).

Authors:  Kevin M Motz; Young J Kim
Journal:  Otolaryngol Clin North Am       Date:  2016-02-20       Impact factor: 3.346

Review 5.  Botulinum toxin therapy: functional silencing of salivary disorders.

Authors:  A Lovato; D A Restivo; G Ottaviano; G Marioni; R Marchese-Ragona
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

6.  Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles.

Authors:  Shang Xie; Kan Wang; Tao Xu; Xue-Sheng Guo; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Cancer Med       Date:  2015-08-26       Impact factor: 4.452

Review 7.  New Uses of AbobotulinumtoxinA in Aesthetics.

Authors:  Joel Schlessinger; Erin Gilbert; Joel L Cohen; Joely Kaufman
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.